Johnson & Johnson (NEO:JNJ)

Market Cap	499.03B
Revenue (ttm)	127.63B
Net Income (ttm)	31.16B
Shares Out	n/a
EPS (ttm)	12.84
PE Ratio	16.01
Forward PE	14.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	26,992
Average Volume	7,694
Open	20.00
Previous Close	20.30
Day's Range	19.53 - 20.00
52-Week Range	18.75 - 22.50
Beta	0.52
RSI	35.55
Earnings Date	Apr 15, 2025

About Johnson & Johnson

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizo...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1886
• Employees: 138,100
• Stock Exchange: Cboe Canada
• Ticker Symbol: JNJ

Financial Performance

In 2024, Johnson & Johnson's revenue was $88.82 billion, an increase of 4.30% compared to the previous year's $85.16 billion. Earnings were $14.07 billion, a decrease of -59.99%.

Financial numbers in USD